Clinical trial
Radiofrequency Ablation of Symptomatic Frequent Ventricular Premature Complexes as a First-line Therapy in Pediatric Population Without Structural Heart Disease
NCT02772354 is registered in ClinicalTrials.gov with Meshalkin Research Institute of Pathology of Circulation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Radiofrequency Ablation of Symptomatic Frequent Ventricular Premature Complexes as a First-line Therapy in Pediatric Population Without Structural Heart Disease
- Lead sponsor
- Meshalkin Research Institute of Pathology of Circulation
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- April 30, 2016
- Completion date
- April 30, 2018
- Enrollment
- 124 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
ventricular arrhythmia